Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value 2025-09-05 16:46
Immunofoco Earns Spot on Forbes Asia 100 to Watch 2025 List for Leading New Wave in Solid Tumor Cell Therapy 2025-09-05 16:09
/DISREGARD RELEASE: Angel Yeast/ 2025-09-05 12:36
Accro Bioscience to Present Phase II Data of AC-201 for Plaque Psoriasis at the European Academy of Dermatology & Venereology Congress 2025 in Paris 2025-09-04 20:24
Global Bio Conference 2025 kicks off in Seoul, charting biotech's future 2025-09-03 20:00
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift 2025-09-02 19:00
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting 2025-09-02 18:00
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights 2025-09-02 17:52
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy 2025-09-02 16:00
Jacobio Pharma Announces 2025 Interim Results 2025-08-30 00:25
Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights 2025-08-29 23:21
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market 2025-08-29 19:30
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025 2025-08-29 17:32
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs 2025-08-28 22:00
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers 2025-08-28 21:00
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee 2025-08-28 20:00
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi 2025-08-28 17:00
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study 2025-08-28 07:45
Harbour BioMed Reports 2025 Interim Results 2025-08-27 22:40
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0 2025-08-27 21:30